CLL Support Association
9,994 members15,622 posts

ASCO 2014: Dr. Furman Gives us Perspective on Resistance with Ibrutinib in CLL


The whole issue of late onset resistance to ibrutinib and other TKIs is a growing area of concern and research.

I will posting more on it in my blog ( ), but Dr. Furman gives us a nice starting perspective.

Stay strong


Admin: Links now working (HU will not cope with any characters adjacent to the end of the link and it is best to have spaces before and after links.)

1 Reply

Excellent video. Thank you. Made me feel very positive. I am about to start on Ibrutinib.


You may also like...